Penserra Capital Management’s Orchard Therapeutics plc American Depositary Shares ORTX Stock Holding History

Penserra Capital Management’s Portfolio ORTX Stock Details ORTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-169	Closed	-$3K	–	1603
2021 Q3	$3K	Buy	169 +17	+11%	+$506	﹤0.01%	1431
2021 Q2	$6K	Buy	152 +13	+9%	+$724	﹤0.01%	1314
2021 Q1	$10K	Sell	139 -1	-0.7%	-$71	﹤0.01%	1041
2020 Q4	$6K	Buy	140 +89	+175%	+$3.99K	﹤0.01%	979
2020 Q3	$2K	Buy	+51	New	+$2.64K	﹤0.01%	913

Other funds holding ORTX

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

PIM

Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return

Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return

Penserra Capital Management's ORTX Position: Q4 2021 in Review

Penserra Capital Management sold out of Orchard Therapeutics plc American Depositary Shares (ORTX) in Q4 2021, closing a stake of 169 shares — an estimated $3K sold.

Penserra Capital Management first reported a position in ORTX in Q3 2020 and held it in 5 quarters. The position peaked at $10K in Q1 2021. 72 funds tracked by Wall St. Rank hold ORTX as of Q4 2021.

Penserra Capital Management reported no remaining Orchard Therapeutics plc American Depositary Shares position as of Q4 2021 after selling out during the quarter.
Penserra Capital Management sold 169 Orchard Therapeutics plc American Depositary Shares shares in Q4 2021, an estimated $3K.
Penserra Capital Management first reported a position in Orchard Therapeutics plc American Depositary Shares in Q3 2020 and held it in 5 quarters.
Penserra Capital Management's Orchard Therapeutics plc American Depositary Shares position peaked at $10K in Q1 2021.
72 funds tracked by Wall St. Rank held Orchard Therapeutics plc American Depositary Shares as of Q4 2021.

Based on Penserra Capital Management's 13F filing for Q4 2021, filed 15 Feb 2022.